Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

Correction: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection

Saved in:
Bibliographic Details
Published in:PloS one Vol. 10; no. 10; p. e0140623
Main Authors: Amin, Janaki, Boyd, Mark A, Kumarasamy, Nagalingeswaran, Moore, Cecilia L, Losso, Marcello H, Nwizu, Chidi A, Mohapi, Lerato, Kerr, Stephen J, Sohn, Annette H, Teppler, Hedy, Renjifo, Boris, Molina, Jean-Michel, Emery, Sean, Cooper, David A
Format: Journal Article
Language:English
Published: United States Public Library of Science 09-10-2015
Public Library of Science (PLoS)
Subjects:
HIV
Human immunodeficiency virus
Lopinavir
Ritonavir
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0140623